Format
Sort by

Send to:

Choose Destination

Results: 5

Cited In for PubMed (Select 16286578)

1.

Carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.

Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Abdelwahab SA, Hassan MK.

Biomed Res Int. 2014;2014:105214. doi: 10.1155/2014/105214. Epub 2014 Jun 4.

2.

Treatment strategies to prevent renal damage in hypertensive children.

Czarniak P, Zurowska A.

Curr Hypertens Rep. 2014 Apr;16(4):423. doi: 10.1007/s11906-014-0423-2. Review.

3.

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.

Wai B, Kearney LG, Hare DL, Ord M, Burrell LM, Srivastava PM.

Cardiovasc Diabetol. 2012 Feb 14;11:14. doi: 10.1186/1475-2840-11-14.

4.

Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.

Hayden MR, Habibi J, Whaley-Connell A, Sowers D, Johnson M, Tilmon R, Jain D, Ferrario C, Sowers JR.

Am J Nephrol. 2010;31(3):262-72. doi: 10.1159/000278757. Epub 2010 Jan 25.

5.

Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.

Whaley-Connell A, Habibi J, Johnson M, Tilmon R, Rehmer N, Rehmer J, Wiedmeyer C, Ferrario CM, Sowers JR.

Am J Nephrol. 2009;30(4):354-60. doi: 10.1159/000229305. Epub 2009 Jul 17.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk